Limited prospective data exist about the clinical relevance of frailty in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) receiving direct oral anticoagulants (DOACs). The aim of this study was to evaluate whether frailty phenotype identifies DOAC-treated patients at higher risk of adverse clinical outcomes.
Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants
Candeloro, Matteo;Di Nisio, Marcello;Potere, Nicola;Di Pizio, Lorenzo;Secinaro, Enzo;De Flaviis, Claudia;Federici, Camilla;Porreca, Ettore
2022-01-01
Abstract
Limited prospective data exist about the clinical relevance of frailty in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) receiving direct oral anticoagulants (DOACs). The aim of this study was to evaluate whether frailty phenotype identifies DOAC-treated patients at higher risk of adverse clinical outcomes.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022-Candeloro-JAGS 2022.pdf
Solo gestori archivio
Tipologia:
Documento in Post-print
Dimensione
811.2 kB
Formato
Adobe PDF
|
811.2 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
